[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day",
    "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=1de1fa66716648b2eb304a2684905f6bda92d48ed92075168359d5ee8f6e8a24",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757695620,
      "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day",
      "id": 136757128,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=1de1fa66716648b2eb304a2684905f6bda92d48ed92075168359d5ee8f6e8a24"
    }
  },
  {
    "ts": null,
    "headline": "Maia’s NSCLC immunotherapy secures Phase II efficacy win",
    "summary": "The biotech is now running a Phase II expansion study to better evaluate the long-term benefits of ateganosine in third-line NSCLC.",
    "url": "https://finnhub.io/api/news?id=527a4136140f6d2d09f614dc8c16c81eb87dcc80c3b0fee84f40db84799c2e71",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757684005,
      "headline": "Maia’s NSCLC immunotherapy secures Phase II efficacy win",
      "id": 136711501,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "The biotech is now running a Phase II expansion study to better evaluate the long-term benefits of ateganosine in third-line NSCLC.",
      "url": "https://finnhub.io/api/news?id=527a4136140f6d2d09f614dc8c16c81eb87dcc80c3b0fee84f40db84799c2e71"
    }
  }
]